Therefore, although these data need further investigation, our observations confirm that Crenigacestat selectively targets NOTCH1 and that the desmoplastic response in iCCA likely plays a key role in both drug effectiveness and tumor progression. This evidence concerns the gene NOTCH1 and infantile convulsions and choreoathetosis.